64 related articles for article (PubMed ID: 21406418)
1. Contaminants in heparin.
Hull R; Walenga J
Clin Appl Thromb Hemost; 2011 Apr; 17(2):125. PubMed ID: 21406418
[No Abstract] [Full Text] [Related]
2. Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
Ramacciotti E; Clark M; Sadeghi N; Hoppensteadt D; Thethi I; Gomes M; Fareed J
Clin Appl Thromb Hemost; 2011 Apr; 17(2):126-35. PubMed ID: 21288929
[TBL] [Abstract][Full Text] [Related]
3. Contaminants in heparins: are all facts known?
Fareed J; Hoppensteadt DA; Ramacciotti E; Hull RD
Clin Appl Thromb Hemost; 2010 Jun; 16(3):242-3. PubMed ID: 20547552
[No Abstract] [Full Text] [Related]
4. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
[No Abstract] [Full Text] [Related]
5. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
[TBL] [Abstract][Full Text] [Related]
6. Contaminated heparin.
Greinacher A; Warkentin TE
N Engl J Med; 2008 Sep; 359(12):1291-2; author reply 1293. PubMed ID: 18799565
[No Abstract] [Full Text] [Related]
7. [Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].
Lindahl U
Lakartidningen; 2008 Sep 24-30; 105(39):2660-1. PubMed ID: 18846871
[No Abstract] [Full Text] [Related]
8. Immunogenic but effective: the HIT-fondaparinux brain puzzler.
Greinacher A
J Thromb Haemost; 2011 Dec; 9(12):2386-8. PubMed ID: 21929685
[No Abstract] [Full Text] [Related]
9. The tainted heparin story: an update.
Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
[TBL] [Abstract][Full Text] [Related]
10. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
Insler SR; Kraenzler EJ; Bartholomew JR; Kottke-Marchant K; Lytle B; Starr NJ
Anesthesiology; 1997 Feb; 86(2):495-8. PubMed ID: 9054269
[No Abstract] [Full Text] [Related]
12. Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.
Schmahl KS; Ganjoo AK; Harloff MG
J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):262-3. PubMed ID: 9106004
[No Abstract] [Full Text] [Related]
13. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
Hu P; Fang L; Chess EK
Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
[TBL] [Abstract][Full Text] [Related]
14. Development of a high-pressure liquid chromatography method for diagnosis of heparin-induced thrombocytopenia.
Koch S; Harenberg J; Odel M; Schmidt-Gayk H; Walch S; Budde U
Am J Clin Pathol; 2002 Jun; 117(6):900-4. PubMed ID: 12047141
[TBL] [Abstract][Full Text] [Related]
15. The use of circular dichroism as a simple heparin-screening strategy.
Stanley FE; Stalcup AM
Anal Bioanal Chem; 2011 Jan; 399(2):701-6. PubMed ID: 20953771
[TBL] [Abstract][Full Text] [Related]
16. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.
Elalamy I; Lecrubier C; Potevin F; Abdelouahed M; Bara L; Marie JP; Samama M
Thromb Haemost; 1995 Nov; 74(5):1384-5. PubMed ID: 8607131
[No Abstract] [Full Text] [Related]
17. From crisis to opportunity: a perspective on the heparin crisis.
Sasisekharan R; Shriver Z
Thromb Haemost; 2009 Nov; 102(5):854-8. PubMed ID: 19888519
[No Abstract] [Full Text] [Related]
18. Contaminated heparin.
Kakkar AK; Bonnefoi M
N Engl J Med; 2008 Sep; 359(12):1292-3; author reply 1293. PubMed ID: 18810795
[No Abstract] [Full Text] [Related]
19. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
Wielgos T; Havel K; Ivanova N; Weinberger R
J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
[TBL] [Abstract][Full Text] [Related]
20. Novel and highly sensitive mixed-polymeric electrokinetic chromatography system for determination of contaminants and impurities of heparin samples.
Tripodi V; Flor S; Dobrecky C; Contin M; Lucangioli S
Electrophoresis; 2010 Oct; 31(21):3606-12. PubMed ID: 20967770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
